Mersana Therapeutics
MRSN
MRSN
82 hedge funds and large institutions have $234M invested in Mersana Therapeutics in 2020 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
15% more capital invested
Capital invested by funds: $203M → $234M (+$30.8M)
0.57% more ownership
Funds ownership: 2.96% → 3.53% (+0.57%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $58K
Holders
82
Holding in Top 10
4
Calls
–
Puts
$58K
Top Buyers
| 1 | +$7M | |
| 2 | +$6.95M | |
| 3 | +$4.82M | |
| 4 |
BlackRock
New York
|
+$4.79M |
| 5 |
Axa
Paris,
France
|
+$2.09M |
Top Sellers
| 1 | -$4.24M | |
| 2 | -$1.69M | |
| 3 | -$1.35M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.16M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$913K |